Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years

NCT06210737 is registered in ClinicalTrials.gov with Beijing Minhai Biotechnology Co., Ltd as lead sponsor.

NCT NCT06210737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
Lead sponsor
Beijing Minhai Biotechnology Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
September 26, 2019
Completion date
November 13, 2022
Enrollment
621 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia